What is CLBS03 High Dose used for?

CLBS03 High Dose is indicated for Ischemic heart failure.

Who makes CLBS03 High Dose?

CLBS03 High Dose is developed by Lisata Therapeutics, Inc..

What development phase is CLBS03 High Dose in?

CLBS03 High Dose is in Phase 2.

What are the side effects of CLBS03 High Dose?

Common side effects include Injection site reaction, Fever, Fatigue.

Last reviewed 2026-04-23 · How we verify

CLBS03 High Dose

Lisata Therapeutics, Inc. · Phase 2 active Biologic

CLBS03 High Dose is a cell therapy that aims to repair or replace damaged heart tissue.

CLBS03 High Dose is a cell therapy that aims to repair or replace damaged heart tissue. Used for Ischemic heart failure.

At a glance

Generic name	CLBS03 High Dose
Sponsor	Lisata Therapeutics, Inc.
Drug class	cell therapy
Modality	Biologic
Therapeutic area	Cardiovascular
Phase	Phase 2

Mechanism of action

CLBS03 High Dose is a high-dose formulation of a cell therapy that utilizes a patient's own bone marrow-derived cells to repair or replace damaged heart tissue. This approach has shown promise in treating heart failure by promoting the growth of new heart tissue and improving cardiac function.

Approved indications

Ischemic heart failure

Common side effects

Injection site reaction
Fever
Fatigue

Key clinical trials

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study) (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results